Skip to main content Accessibility help

Amyloid Burden, Neuronal Function, and Cognitive Decline in Middle-Aged Adults at Risk for Alzheimer's Disease

  • Ozioma C. Okonkwo (a1) (a2) (a3), Jennifer M. Oh (a1) (a2), Rebecca Koscik (a3), Erin Jonaitis (a3), Caitlin A. Cleary (a1) (a2), N. Maritza Dowling (a2) (a4), Barbara B. Bendlin (a1) (a2) (a3), Asenath LaRue (a3), Bruce P. Hermann (a2) (a3) (a5), Todd E. Barnhart (a6), Dhanabalan Murali (a6), Howard A. Rowley (a2) (a7), Cynthia M. Carlsson (a1) (a2) (a3), Catherine L. Gallagher (a1) (a2) (a5), Sanjay Asthana (a1) (a2) (a3), Mark A. Sager (a2) (a3), Brad T. Christian (a2) (a6) and Sterling C. Johnson (a1) (a2) (a3)...


The relative influence of amyloid burden, neuronal structure and function, and prior cognitive performance on prospective memory decline among asymptomatic late middle-aged individuals at risk for Alzheimer's disease (AD) is currently unknown. We investigated this using longitudinal cognitive data from 122 middle-aged adults (21 “Decliners” and 101 “Stables”) enrolled in the Wisconsin Registry for Alzheimer's Prevention who underwent multimodality neuroimaging [11C-Pittsburgh Compound B (PiB), 18F-fluorodeoxyglucose (FDG), and structural/functional magnetic resonance imaging (fMRI)] 5.7 ± 1.4 years (range = 2.9–8.9) after their baseline cognitive assessment. Covariate-adjusted regression analyses revealed that the only imaging measure that significantly distinguished Decliners from Stables (p = .027) was a Neuronal Function composite derived from FDG and fMRI. In contrast, several cognitive measures, especially those that tap episodic memory, significantly distinguished the groups (p's<.05). Complementary receiver operating characteristic curve analyses identified the Brief Visuospatial Memory Test-Revised (BVMT-R) Total (.82 ± .05, p < .001), the BVMT-R Delayed Recall (.73 ± .06, p = .001), and the Reading subtest from the Wide-Range Achievement Test-III (.72 ± .06, p = .002) as the top three measures that best discriminated the groups. These findings suggest that early memory test performance might serve a more clinically pivotal role in forecasting future cognitive course than is currently presumed. (JINS, 2014, 20, 1–12)


Corresponding author

Correspondence and reprint requests to: Ozioma C. Okonkwo, Department of Medicine and Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792. E-mail:


Hide All
Alzheimer's Association. (2012). 2012 Alzheimer's disease facts and figures. Alzheimer's & Dementia, 8(2), 131168. doi:10.1016/j.jalz.2012.02.001
Benedict, R.H.B. (1997). Brief Visuospatial Memory Test-Revised. Odessa, FL: Psychological Assessment Resources, Inc.
Benton, A.L. (1994). Neuropsychological assessment. Annual Review of Psychology, 45, 123. doi:10.1146/
Benton, A.L., Hamsher, K., Sivan, A.B. (1976). Multilingual Aphasia Examination. Iowa City, IA: AJA Associates.
Blacker, D., Lee, H., Muzikansky, A., Martin, E.C., Tanzi, R., McArdle, J.J., Albert, M. (2007). Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Archives of Neurology, 64(6), 862871. doi:10.1001/archneur.64.6.862
Buckner, R.L., Snyder, A.Z., Shannon, B.J., LaRossa, G., Sachs, R., Fotenos, A.F., Mintun, M.A. (2005). Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. Journal of Neuroscience, 25(34), 77097717. doi:10.1523/JNEUROSCI.2177-05.2005
Cairns, N.J., Ikonomovic, M.D., Benzinger, T., Storandt, M., Fagan, A.M., Shah, A.R., Morris, J.C. (2009). Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: A case report. Archives of Neurology, 66(12), 15571562. doi:10.1001/archneurol.2009.279
Chetelat, G. (2013). Alzheimer disease: Abeta-independent processes-rethinking preclinical AD. Nature Reviews Neurology, 9(3), 123124. doi:10.1038/nrneurol.2013.21
Chételat, G., La Joie, R., Villain, N., Perrotin, A., de La Sayette, V., Eustache, F., Vandenberghe, R. (2013). Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease. Neuroimage: Clinical, 2, 356365. doi:
Christian, B.T., Vandehey, N.T., Floberg, J.M., Mistretta, C.A. (2010). Dynamic PET denoising with HYPR processing. Journal of Nuclear Medicine, 51(7), 11471154. doi:10.2967/jnumed.109.073999
Corder, E.H., Ghebremedhin, E., Taylor, M.G., Thal, D.R., Ohm, T.G., Braak, H. (2004). The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: Modification by age, sex, and APOE polymorphism. Annals of the New York Academy of Sciences, 1019, 2428. doi:10.1196/annals.1297.005
Desikan, R.S., McEvoy, L.K., Thompson, W.K., Holland, D., Brewer, J.B., Aisen, P.S., Dale, A.M. (2012). Amyloid-beta—associated clinical decline occurs only in the presence of elevated P-tau. Archives of Neurology, 69(6), 709713. doi:10.1001/archneurol.2011.3354
Drachman, D.A. (2006). Aging of the brain, entropy, and Alzheimer disease. Neurology, 67(8), 13401352. doi:10.1212/01.wnl.0000240127.89601.83
Elias, M.F., Beiser, A., Wolf, P.A., Au, R., White, R.F., D'Agostino, R.B. (2000). The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Archives of Neurology, 57(6), 808813.
Ewers, M., Insel, P., Jagust, W.J., Shaw, L., Trojanowski, J.Q., Aisen, P., Weiner, M.W. (2012). CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cerebral Cortex, 22(9), 19932004. doi:10.1093/cercor/bhr271
Floberg, J.M., Mistretta, C.A., Weichert, J.P., Hall, L.T., Holden, J.E., Christian, B.T. (2012). Improved kinetic analysis of dynamic PET data with optimized HYPR-LR. Medical Physics, 39(6), 33193331. doi:10.1118/1.4718669
Folstein, M.F., Folstein, S.E., McHugh, P.R. (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.
Heaton, R.K., Chelune, G.J., Talley, J.L., Kay, G.G., Curtiss, G. (1993). Wisconsin Card Sorting Test Manual. Odessa, FL: Psychological Assessment Resources, Inc.
Hedden, T., Oh, H., Younger, A.P., Patel, T.A. (2013). Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology, 80(14), 13411348. doi:10.1212/WNL.0b013e31828ab35d
Huijbers, W., Vannini, P., Sperling, R.A., C.M.P., , Cabeza, R., Daselaar, S.M. (2012). Explaining the encoding/retrieval flip: Memory-related deactivations and activations in the posteromedial cortex. Neuropsychologia, 50(14), 37643774. doi:10.1016/j.neuropsychologia.2012.08.021
Jack, C.R. Jr., Knopman, D.S., Jagust, W.J., Petersen, R.C., Weiner, M.W., Aisen, P.S., Trojanowski, J.Q. (2013). Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurology, 12(2), 207216. doi:10.1016/S1474-4422(12)70291-0
Jack, C.R. Jr., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Trojanowski, J.Q. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology, 9(1), 119128. doi:10.1016/S1474-4422(09)70299-6
Jack, C.R. Jr., Lowe, V.J., Weigand, S.D., Wiste, H.J., Senjem, M.L., Knopman, D.S., Petersen, R.C. (2009). Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain, 132(Pt 5), 13551365. doi:10.1093/brain/awp062
Jagust, W.J., Bandy, D., Chen, K., Foster, N.L., Landau, S.M., Mathis, C.A., Koeppe, R.A. (2010). The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's & Dementia, 6(3), 221229. doi:10.1016/j.jalz.2010.03.003
Johnson, S.C., Schmitz, T.W., Moritz, C.H., Meyerand, M.E., Rowley, H.A., Alexander, A.L., Alexander, G.E. (2006). Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment. Neurobiology of Aging, 27(11), 16041612. doi:10.1016/j.neurobiolaging.2005.09.017
Kaplan, E., Goodglass, H., Weintraub, S. (1983). Boston Naming Test. Philadelphia: Lea & Febiger.
Kawas, C.H., Corrada, M.M., Brookmeyer, R., Morrison, A., Resnick, S.M., Zonderman, A.B., Arenberg, D. (2003). Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology, 60(7), 10891093.
Landau, S.M., Harvey, D., Madison, C.M., Koeppe, R.A., Reiman, E.M., Foster, N.L., Jagust, W.J. (2011). Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiology of Aging, 32(7), 12071218. doi:10.1016/j.neurobiolaging.2009.07.002
Landau, S.M., Harvey, D., Madison, C.M., Reiman, E.M., Foster, N.L., Aisen, P.S., Jagust, W.J. (2010). Comparing predictors of conversion and decline in mild cognitive impairment. Neurology, 75(3), 230238. doi:10.1212/WNL.0b013e3181e8e8b8
Landau, S.M., Mintun, M.A., Joshi, A.D., Koeppe, R.A., Petersen, R.C., Aisen, P.S., Jagust, W.J. (2012). Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Annals of Neurology, 72(4), 578586. doi:10.1002/ana.23650
Leech, R., Sharp, D.J. (2013). The role of the posterior cingulate cortex in cognition and disease. Brain. doi:10.1093/brain/awt162
Lim, Y.Y., Ellis, K.A., Pietrzak, R.H., Ames, D., Darby, D., Harrington, K., Maruff, P. (2012). Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology, 79(16), 16451652. doi:10.1212/WNL.0b013e31826e9ae6
Lo, R.Y., Hubbard, A.E., Shaw, L.M., Trojanowski, J.Q., Petersen, R.C., Aisen, P.S., Jagust, W.J. (2011). Longitudinal change of biomarkers in cognitive decline. Archives of Neurology, 68(10), 12571266. doi:10.1001/archneurol.2011.123
Maldjian, J.A., Laurienti, P.J., Kraft, R.A., Burdette, J.H. (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage, 19, 12331239. doi:S1053811903001691 [pii]
Manly, J.J., Schupf, N., Tang, M.X., Stern, Y. (2005). Cognitive decline and literacy among ethnically diverse elders. Journal of Geriatric Psychiatry and Neurology, 18(4), 213217. doi:10.1177/0891988705281868
Morris, J.C. (1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43, 24122414.
Morris, J.C., Roe, C.M., Grant, E.A., Head, D., Storandt, M., Goate, A.M., Mintun, M.A. (2009). Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Archives of Neurology, 66(12), 14691475. doi:10.1001/archneurol.2009.269
Mosconi, L., Mistur, R., Switalski, R., Brys, M., Glodzik, L., Rich, K., de Leon, M.J. (2009). Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology, 72(6), 513520. doi:10.1212/01.wnl.0000333247.51383.43
O'Brien, J.L., O'Keefe, K.M., LaViolette, P.S., DeLuca, A.N., Blacker, D., Dickerson, B.C., Sperling, R.A. (2010). Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology, 74(24), 19691976. doi:10.1212/WNL.0b013e3181e3966e
Okonkwo, O.C., Xu, G., Dowling, N.M., Bendlin, B.B., Larue, A., Hermann, B.P., Johnson, S.C. (2012). Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults. Neurology, 78(22), 17691776. doi:10.1212/WNL.0b013e3182583047
Okonkwo, O.C., Xu, G., Oh, J.M., Dowling, N.M., Carlsson, C.M., Gallagher, C.L., Johnson, S.C. (2012). Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease. Cerebral Cortex [Epub ahead of print].
Price, J.C., Klunk, W.E., Lopresti, B.J., Lu, X., Hoge, J.A., Ziolko, S.K., Mathis, C.A. (2005). Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. Journal of Cerebral Blood Flow and Metabolism, 25(11), 15281547. doi:10.1038/sj.jcbfm.9600146
Rami, L., Sala-Llonch, R., Sole-Padulles, C., Fortea, J., Olives, J., Llado, A., Molinuevo, J.L. (2012). Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease. Journal of Alzheimer's Disease, 31(3), 517526. doi:10.3233/JAD-2012-120223
Reitan, R., Wolfson, D. (1993). The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation. Tucson: Neuropsychology Press.
Rentz, D.M., Locascio, J.J., Becker, J.A., Moran, E.K., Eng, E., Buckner, R.L., Johnson, K.A. (2010). Cognition, reserve, and amyloid deposition in normal aging. Annals of Neurology, 67(3), 353364. doi:10.1002/ana.21904
Resnick, S.M., Sojkova, J., Zhou, Y., An, Y., Ye, W., Holt, D.P., Wong, D.F. (2010). Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology, 74(10), 807815. doi:10.1212/WNL.0b013e3181d3e3e9
Sager, M.A., Hermann, B., La Rue, A. (2005). Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. Journal of Geriatric Psychiatry and Neurology, 18(4), 245249. doi:10.1177/0891988705281882
Schmidt, M. (1996). Rey Auditory Verbal Learning Test: A handbook. Torrance, CA: Western Psychological Services.
Sheline, Y.I., Morris, J.C., Snyder, A.Z., Price, J.L., Yan, Z., D'Angelo, G., Mintun, M.A. (2010). APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42. Journal of Neuroscience, 30(50), 1703517040. doi:10.1523/JNEUROSCI.3987-10.2010
Snitz, B.E., Weissfeld, L.A., Lopez, O.L., Kuller, L.H., Saxton, J., Singhabahu, D.M., Dekosky, S.T. (2013). Cognitive trajectories associated with beta-amyloid deposition in the oldest-old without dementia. Neurology, 80, 13781384. doi:10.1212/WNL.0b013e31828c2fc8
Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., Phelps, C.H. (2011). Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7(3), 280292. doi:10.1016/j.jalz.2011.03.003
Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurology, 11(11), 10061012. doi:10.1016/S1474-4422(12)70191-6
Strauss, E., Sherman, E.M.S., Spreen, O. (2006). A compendium of neuropsychological tests (3rd ed). Oxford: Oxford University Press.
Trenerry, M., Crosson, B., DeBoe, J., Leber, L. (1989). Stroop Neuropsychological Screening Test. Odessa, FL: Psychological Assessment Resources, Inc.
Vannini, P., O'Brien, J., O'Keefe, K., Pihlajamaki, M., Laviolette, P., Sperling, R.A. (2011). What goes down must come up: Role of the posteromedial cortices in encoding and retrieval. Cerebral Cortex, 21(1), 2234. doi:10.1093/cercor/bhq051
Villemagne, V.L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K.A., Salvado, O., Masters, C.L. (2013). Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. Lancet Neurology, 12(4), 357367. doi:10.1016/S1474-4422(13)70044-9
Vina, J., Lloret, A. (2010). Why women have more Alzheimer's disease than men: Gender and mitochondrial toxicity of amyloid-beta peptide. Journal of Alzheimer's Disease, 20(Suppl 2), S527S533. doi:10.3233/JAD-2010-100501
Wechsler, D. (1987). Wechsler Memory Scale—Revised edition. San Antonio, TX: The Psychological Corporation.
Wechsler, D. (1997). WAIS-III: Wechsler Adult Intelligence Scale—3rd edition. San Antonio, TX: The Psychological Corporation.
Wechsler, D. (1999). Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: The Psychological Corporation.
Wilkinson, G. (1993). Wide Range Achievement Test Administration Manual (3rd ed). Wilmington, Delaware: Wide Range Incorporated.
Wirth, M., Madison, C.M., Rabinovici, G.D., Oh, H., Landau, S.M., Jagust, W.J. (2013). Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not beta-amyloid in cognitively normal older individuals. Journal of Neuroscience, 33(13), 55535563. doi:10.1523/JNEUROSCI.4409-12.2013
Wirth, M., Oh, H., Mormino, E.C., Markley, C., Landau, S.M., Jagust, W.J. (2013). The effect of amyloid beta on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimer's & Dementia. doi:10.1016/j.jalz.2012.10.012
Xu, G., McLaren, D.G., Ries, M.L., Fitzgerald, M.E., Bendlin, B.B., Rowley, H.A., Johnson, S.C. (2009). The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory. Brain, 132(Pt 2), 383391. doi:10.1093/brain/awn254
Zhou, X., Obuchowski, N., McClish, D. (2011). Statistical methods in diagnostic medicine (2nd ed). Hoboken, NJ: John Wiley & Sons, Inc.


Related content

Powered by UNSILO
Type Description Title
Supplementary materials

Okonkwo Supplementary Material

 Word (152 KB)
152 KB

Amyloid Burden, Neuronal Function, and Cognitive Decline in Middle-Aged Adults at Risk for Alzheimer's Disease

  • Ozioma C. Okonkwo (a1) (a2) (a3), Jennifer M. Oh (a1) (a2), Rebecca Koscik (a3), Erin Jonaitis (a3), Caitlin A. Cleary (a1) (a2), N. Maritza Dowling (a2) (a4), Barbara B. Bendlin (a1) (a2) (a3), Asenath LaRue (a3), Bruce P. Hermann (a2) (a3) (a5), Todd E. Barnhart (a6), Dhanabalan Murali (a6), Howard A. Rowley (a2) (a7), Cynthia M. Carlsson (a1) (a2) (a3), Catherine L. Gallagher (a1) (a2) (a5), Sanjay Asthana (a1) (a2) (a3), Mark A. Sager (a2) (a3), Brad T. Christian (a2) (a6) and Sterling C. Johnson (a1) (a2) (a3)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.